[HTML][HTML] Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
D Łażewska, A Olejarz-Maciej, D Reiner… - International journal of …, 2020 - mdpi.com
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H3 receptor (H3R) …
combination of monoamine oxidase B (MAO B) inhibition with histamine H3 receptor (H3R) …
Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors.
D Łażewska, A Olejarz-Maciej, D Reiner… - … Journal of Molecular …, 2020 - europepmc.org
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H 3 receptor (H 3 R) …
combination of monoamine oxidase B (MAO B) inhibition with histamine H 3 receptor (H 3 R) …
Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
D Łażewska, A Olejarz-Maciej… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H 3 receptor (H 3 R) …
combination of monoamine oxidase B (MAO B) inhibition with histamine H 3 receptor (H 3 R) …
[HTML][HTML] Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
D Łażewska, A Olejarz-Maciej, D Reiner… - … Journal of Molecular …, 2020 - ncbi.nlm.nih.gov
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H 3 receptor (H 3 R) …
combination of monoamine oxidase B (MAO B) inhibition with histamine H 3 receptor (H 3 R) …
Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
D Łażewska, A Olejarz-Maciej, D Reiner, M Kaleta… - 2020 - agris.fao.org
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H< sub> 3</sub> …
combination of monoamine oxidase B (MAO B) inhibition with histamine H< sub> 3</sub> …
[PDF][PDF] Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
D Łazewska, A Olejarz-Maciej, D Reiner, M Kaleta… - Int. J. Mol. Sci, 2020 - academia.edu
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H3 receptor (H3R) …
combination of monoamine oxidase B (MAO B) inhibition with histamine H3 receptor (H3R) …
[PDF][PDF] Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
D Łazewska, A Olejarz-Maciej, D Reiner… - Int. J. Mol …, 2020 - pdfs.semanticscholar.org
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H3 receptor (H3R) …
combination of monoamine oxidase B (MAO B) inhibition with histamine H3 receptor (H3R) …
Dual target ligands with 4-tert-butylphenoxy scaffold as histamine H3 receptor antagonists and monoamine oxidase B inhibitors
D Łażewska, A Olejarz-Maciej, D Reiner… - International Journal of …, 2020 - ruj.uj.edu.pl
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H3 receptor (H3R) …
combination of monoamine oxidase B (MAO B) inhibition with histamine H3 receptor (H3R) …
Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors.
D Łażewska, A Olejarz-Maciej… - International …, 2020 - search.ebscohost.com
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H< sub> 3 receptor …
combination of monoamine oxidase B (MAO B) inhibition with histamine H< sub> 3 receptor …
Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
D Łażewska, A Olejarz-Maciej, D Reiner… - International …, 2020 - search.proquest.com
Dual target ligands are a promising concept for the treatment of Parkinson's disease (PD). A
combination of monoamine oxidase B (MAO B) inhibition with histamine H 3 receptor (H 3 R) …
combination of monoamine oxidase B (MAO B) inhibition with histamine H 3 receptor (H 3 R) …